3-[2-(pyrrolidin-1-yl)ethyl]indoles and 3-[3-(piperidin-1-yl)propyl]indoles: Agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B subtype

被引：17

作者：

Castro, JL ^{[1
]}

Street, LJ ^{[1
]}

Guiblin, AR ^{[1
]}

Jelley, RA ^{[1
]}

Russell, MGN ^{[1
]}

Sternfeld, F ^{[1
]}

Beer, MS ^{[1
]}

Stanton, JA ^{[1
]}

Matassa, VG ^{[1
]}

机构：

[1] MERCK SHARP & DOHME LTD,RES LABS,NEUROSCI RES CTR,DEPT BIOCHEM,HARLOW CM20 2QR,ESSEX,ENGLAND

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1997年 / 40卷 / 22期

关键词：

D O I：

10.1021/jm9704558

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：3497 / 3500

页数：6

共 24 条

[1] 5-HT RECEPTORS MEDIATING CONTRACTIONS OF THE ISOLATED HUMAN CORONARY-ARTERY [J].

BAX, WA ;

RENZENBRINK, GJ ;

VANHEUVENNOLSEN, D ;

THIJSSEN, EJM ;

BOS, E ;

SAXENA, PR .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 239 (1-3) :203-210

[2]

Bouchelet I, 1996, MOL PHARMACOL, V50, P219

[3] Modeling of the agonist binding site of serotonin human 5-HT1A, 5-HT1D alpha and 5-HT1D beta receptors [J].

Bremner, DH ;

Ringan, NS ;

Wishart, G .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1997, 32 (01) :59-69

[4]

CASTRO JL, 1996, Patent No. 4274

[5] SYNTHESIS OF THE 5-HT1D RECEPTOR AGONIST MK-0462 VIA A PD-CATALYZED COUPLING REACTION [J].

CHEN, CY ;

LIEBERMAN, DR ;

LARSEN, RD ;

REAMER, RA ;

VERHOEVEN, TR ;

REIDER, PJ ;

COTTRELL, IF ;

HOUGHTON, PG .

TETRAHEDRON LETTERS, 1994, 35 (38) :6981-6984

[6] Pilot study of MK-462 in migraine [J].

Cutler, NR ;

Claghorn, J ;

Sramek, JJ ;

Block, G ;

Panebianco, D ;

Cheng, H ;

Olah, TV ;

Reines, SA .

CEPHALALGIA, 1996, 16 (02) :113-116

[7]

Ferrari M D, 1993, Neurology, V43, pS43

[8] CLINICAL AND EXPERIMENTAL EFFECTS OF SUMATRIPTAN IN HUMANS [J].

FERRARI, MD ;

SAXENA, PR .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (04) :129-133

[9] A COMPARISON OF THE CONTRACTILE EFFECTS OF 5-HYDROXYTRYPTAMINE, SUMATRIPTAN AND MK-462 ON HUMAN CORONARY-ARTERY IN-VITRO [J].

FERRO, A ;

LONGMORE, J ;

HILL, RG ;

BROWN, MJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 40 (03) :245-251

[10]

HAMEL E, 1993, MOL PHARMACOL, V44, P242

← 1 2 3 →